| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF03345237 |
| P698 | PubMed publication ID | 14964439 |
| P2093 | author name string | Giordano R | |
| Gianotti L | |||
| Arvat E | |||
| Lanfranco F | |||
| Maccario M | |||
| Pellegrino M | |||
| P2860 | cites work | The effect of recombinant human growth hormone on malnourished older individuals | Q70119898 |
| Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance | Q70143979 | ||
| Regulation of growth hormone and somatomedin-C secretion in postmenopausal women: effect of physiological estrogen replacement | Q70293791 | ||
| Effects of sex and age on growth hormone response to growth hormone-releasing hormone in healthy individuals | Q70355792 | ||
| Effect of aging on human plasma growth hormone response to clonidine | Q70654179 | ||
| Brain acetylcholine synthesis declines with senescence | Q70844710 | ||
| Intracerebroventricular growth-hormone-releasing peptide-6 stimulates eating without affecting plasma growth hormone responses in rats | Q71040673 | ||
| Growth hormone increases muscle mass and strength but does not rejuvenate myofibrillar protein synthesis in healthy subjects over 60 years old | Q71477166 | ||
| Function of the GH/IGF-1 axis in healthy middle-aged male runners | Q71504379 | ||
| Adult lean body mass declines with age: some longitudinal observations | Q71543853 | ||
| Age-related reduction of human growth hormone-binding sites in the human brain | Q72612560 | ||
| Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults | Q72628858 | ||
| Effect of a sustained program of resistance training on the acute growth hormone response to resistance exercise in older adults | Q72802669 | ||
| Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men | Q73006825 | ||
| Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans | Q73048216 | ||
| Use of human GH in elderly patients with accidental hip fracture | Q73191643 | ||
| Age-related variations in the neuroendocrine control, more than impaired receptor sensitivity, cause the reduction in the GH-releasing activity of GHRPs in human aging | Q73196664 | ||
| Relationship of physical exercise and ageing to growth hormone production | Q73321701 | ||
| The endocrinology of aging | Q73797354 | ||
| Peak oxygen uptake, muscle volume, and the growth hormone-insulin-like growth factor-I axis in adolescent males | Q74495751 | ||
| Ghrelin is a growth-hormone-releasing acylated peptide from stomach | Q22010951 | ||
| Effects of human growth hormone in men over 60 years old | Q28288413 | ||
| Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults | Q30310412 | ||
| Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects | Q30469767 | ||
| Effect of aging on the sensitivity of growth hormone secretion to insulin-like growth factor-I negative feedback | Q30470958 | ||
| Human growth hormone response to repeated bouts of aerobic exercise | Q30471317 | ||
| Growth hormone-releasing hormone and growth hormone secretagogue-receptor ligands: focus on reproductive system | Q30650663 | ||
| Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. | Q32131517 | ||
| Endocrine and non-endocrine activities of growth hormone secretagogues in humans | Q33791357 | ||
| Insulin-Like growth factor I: implications in aging | Q33873279 | ||
| Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men. | Q33913330 | ||
| Hypothalamic growth hormone-insulin-like growth factor-I axis across the human life span | Q34153780 | ||
| Unnatural growth hormone-releasing peptide begets natural ghrelin | Q34215684 | ||
| Growth hormone binding protein 2001. | Q34235525 | ||
| Hormonal and growth factor responses to heavy resistance exercise protocols | Q34277016 | ||
| Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man. | Q34337041 | ||
| Testosterone, growth hormone and IGF-I responses to acute and chronic resistive exercise in men aged 55-70 years | Q34370225 | ||
| Acute hormonal responses to heavy resistance exercise in men and women at different ages | Q34394172 | ||
| Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity | Q34635506 | ||
| Growth hormone, insulin-like growth factor-1 and the aging cardiovascular system | Q34683077 | ||
| Ageing, hormones, body composition, metabolic effects | Q34712038 | ||
| GH-related and extra-endocrine actions of GH secretagogues in aging. | Q34977022 | ||
| Performance and physiologic adaptations to resistance training | Q34985354 | ||
| Ageing and local growth factors in muscle | Q35048468 | ||
| Endocrine and non-endocrine actions of ghrelin. | Q35085533 | ||
| Three-peptide control of pulsatile and entropic feedback-sensitive modes of growth hormone secretion: modulation by estrogen and aromatizable androgen. | Q35149076 | ||
| The exercise-induced growth hormone response in athletes | Q35150198 | ||
| Sleep and endocrinology | Q35161358 | ||
| Impaired growth hormone secretion in the adult population: relation to age and adiposity | Q36998642 | ||
| Regulation of energy expenditure in aging humans | Q37946514 | ||
| Testosterone and oxandrolone, a nonaromatizable androgen, specifically amplify the mass and rate of growth hormone (GH) secreted per burst without altering GH secretory burst duration or frequency or the GH half-life | Q39102575 | ||
| Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations | Q39105413 | ||
| Effects of growth hormone replacement on physical performance and body composition in GH deficient adults | Q40799193 | ||
| Human growth hormone and human aging | Q40906146 | ||
| Spontaneous Growth Hormone Secretion Increases during Puberty in Normal Girls and Boys* | Q41156184 | ||
| Human aging and the GH-IGF-I axis. | Q41184176 | ||
| Beneficial effects of growth hormone treatment in GH-deficient adults | Q41230604 | ||
| Growth hormone-releasing peptides | Q41500345 | ||
| Age-related growth hormone-releasing activity of growth hormone secretagogues in humans | Q41663165 | ||
| Somatopause and adiposity | Q41684826 | ||
| High-intensity strength training in nonagenarians. Effects on skeletal muscle | Q42154425 | ||
| Metabolic modulation of the growth hormone-releasing activity of hexarelin in man. | Q42489063 | ||
| Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects. | Q42493112 | ||
| Increased secretion of somatostatin-28 from hypothalamic neurons of aged rats in vitro | Q42503748 | ||
| Diminished pituitary responsiveness to growth hormone-releasing factor in aging male rats | Q42508292 | ||
| Effects of insulin on rat anterior pituitary cells. Inhibition of growth hormone secretion and mRNA levels | Q42511038 | ||
| Physical activity and health | Q43188857 | ||
| Growth hormone replacement in healthy older men improves body composition but not functional ability | Q43506669 | ||
| Effects of GH and/or sex steroid administration on abdominal subcutaneous and visceral fat in healthy aged women and men. | Q43705618 | ||
| Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men | Q44014137 | ||
| Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial | Q44212056 | ||
| The endocrine response to ghrelin as a function of gender in humans in young and elderly subjects | Q44392855 | ||
| Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone-releasing hormone | Q44502668 | ||
| Serum Sex Hormones, IGF-1, and IGFBP3 Exert a Sexually Dimorphic Effect on Lean Body Mass in Aging | Q44514751 | ||
| Age or waist as determinant of insulin action? | Q44517902 | ||
| Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. | Q44947096 | ||
| Evidence for a direct pituitary inhibition by free fatty acids of in vivo growth hormone responses to growth hormone-releasing hormone in the rat. | Q45127749 | ||
| Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men. | Q45962289 | ||
| Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. | Q45999435 | ||
| Effects of short term administration of recombinant human growth hormone to elderly people | Q46191802 | ||
| Effect of growth hormone and resistance exercise on muscle growth in young men. | Q46942923 | ||
| The effects of recombinant human insulin-like growth factor-I and growth hormone on body composition in elderly women | Q46972658 | ||
| Growth hormone responses during intermittent weight lifting exercise in men. | Q47244704 | ||
| Serum free IGF-I, total IGF-I, IGFBP-1 and IGFBP-3 levels in an elderly population: relation to age and sex steroid levels. | Q47926827 | ||
| Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release | Q48330103 | ||
| The insulin-like growth factor-I generation test: peripheral responsiveness to growth hormone is not decreased with ageing | Q48390391 | ||
| Neuroendocrine rhythms and sleep in aging men. | Q48907316 | ||
| Growth hormone-deficient young adults have decreased deep sleep | Q48932747 | ||
| Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). | Q51028523 | ||
| Physical and psychological capabilities during substitution therapy with recombinant growth hormone in adults with growth hormone deficiency. | Q51166690 | ||
| Growth hormone secretion enhanced by androgens. | Q51190371 | ||
| The effect of growth hormone replacement therapy for up to 12 months on lipoprotein composition and lipoprotein(a) in growth hormone-deficient adults. | Q51574175 | ||
| Hypoglycemia: a potent stimulus to secretion of growth hormone. | Q51692790 | ||
| Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. | Q52533086 | ||
| Five years of growth hormone replacement therapy in adults: age- and gender-related changes in isometric and isokinetic muscle strength. | Q53862981 | ||
| Effect of regular physical training on age-associated alteration of body composition in men. | Q53994278 | ||
| Short and long-term cardiovascular effects of growth hormone therapy in growth hormone deficient adults. | Q54021844 | ||
| Does growth hormone therapy in conjunction with resistance exercise increase muscle force production and muscle mass in men and women aged 60 years or older? | Q54107242 | ||
| Effect of growth hormone and resistance exercise on muscle growth and strength in older men. | Q54180544 | ||
| Effects of progressive resistance training on growth hormone and testosterone levels in young and elderly subjects. | Q54347233 | ||
| The importance of growth hormone in the regulation of erythropoiesis, red cell mass, and plasma volume in adults with growth hormone deficiency. | Q55067183 | ||
| Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone r | Q56883933 | ||
| Growth hormone enhances effects of endurance training on oxidative muscle metabolism in elderly women | Q57420686 | ||
| The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients | Q57420747 | ||
| The IGF-I response to very low rhGH doses is preserved in human ageing | Q60674333 | ||
| Regulation of somatotroph cell function by the adipose tissue | Q60693604 | ||
| Serum IGF-binding protein-3 is related to IGF-I, but not to spontaneous GH release, in healthy old men | Q67464864 | ||
| Metabolic responses to exercise in young and older athletes and sedentary men | Q67931140 | ||
| Restoration of normal growth hormone responsiveness to GHRH in normal aged men by infusion of low amounts of theophylline | Q67970716 | ||
| Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man | Q68586058 | ||
| Human growth hormone release during sleep: electroencephalographic correlation | Q68594822 | ||
| Effect of testosterone on growth hormone secretion in patients with anorchia and delayed puberty | Q68609584 | ||
| Nyctohemeral growth hormone profiles in young and aged men: correlation with somatomedin-C levels | Q68963637 | ||
| Relationship between growth hormone-releasing hormone and somatostatin in the rat: effects of age and sex on content and in-vitro release from hypothalamic explants | Q69375460 | ||
| Aging, Total Body Potassium, Fat-free Mass, and Cell Mass in Males and Females Between Ages 18 and 85 Years | Q69377354 | ||
| Changes in skeletal muscle after discontinuation of growth hormone treatment in young adults with hypopituitarism | Q69800488 | ||
| The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals | Q70061030 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 861-872 | |
| P577 | publication date | 2003-09-01 | |
| P1433 | published in | Journal of Endocrinological Investigation | Q15766847 |
| P1476 | title | Ageing, growth hormone and physical performance | |
| P478 | volume | 26 |
| Q46767604 | Are insulin resistance, impaired fasting glucose and impaired glucose tolerance all equally strongly related to age? |
| Q64122592 | Body Composition, IGF1 Status, and Physical Functionality in Nonagenarians: Implications for Osteosarcopenia |
| Q37590756 | Carotid Intima Media Thickness Is Independently Associated with Male Gender, Middle Age, and IGF-1 in Metabolically Healthy Obese Individuals. |
| Q33624771 | Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies |
| Q36211439 | Class II G protein-coupled receptors and their ligands in neuronal function and protection |
| Q30445850 | Deafness and permanently reduced potassium channel gene expression and function in hypothyroid Pit1dw mutants. |
| Q34575235 | Determination of therapeutics with growth-hormone secretagogue activity in human urine for doping control purposes |
| Q51754472 | Effect of chronic treatments with GH, melatonin, estrogens, and phytoestrogens on oxidative stress parameters in liver from aged female rats. |
| Q33667282 | Effect of regular yogic training on growth hormone and dehydroepiandrosterone sulfate as an endocrine marker of aging |
| Q46879659 | Effect of rehabilitation program on endocrinological parameters in patients with COPD and in healthy subjects |
| Q37409213 | Effects of Growth Hormone Administration on Muscle Strength in Men over 50 Years Old |
| Q43011976 | Effects of growth hormone, melatonin, oestrogens and phytoestrogens on the oxidized glutathione (GSSG)/reduced glutathione (GSH) ratio and lipid peroxidation in aged ovariectomized rats |
| Q27014666 | Emerging options in growth hormone therapy: an update |
| Q93036908 | Hormones as adaptive control systems in juvenile fish |
| Q58790354 | Klotho, the Key to Healthy Brain Aging? |
| Q36726338 | New treatments for chronic obstructive pulmonary disease using ergogenic aids |
| Q37088482 | Progesterone and vitamin d hormone as a biologic treatment of traumatic brain injury in the aged |
| Q47190175 | Redefining diabetes and the concept of self-management from a patient's perspective: implications for disease risk factor management. |
| Q43815914 | Serum insulin-like growth factor I and its binding protein 3 in their relation to intima-media thickness: results of the study of health in Pomerania (SHIP). |
| Q46321376 | Soy protein based supplementation supports metabolic effects of resistance training in previously untrained middle aged males |
| Q48670361 | Sustained-release recombinant human growth hormone improves body composition and quality of life in adults with somatopause |
| Q33709653 | Traumatic brain injury and aging: is a combination of progesterone and vitamin D hormone a simple solution to a complex problem? |
| Q91691045 | Voluntary wheel running delays brain atrophy in aged mice |
Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120 Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120
Search more.